Spots Global Cancer Trial Database for qs21
Every month we try and update this database with for qs21 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Vaccine Therapy Plus QS21 in Treating Patients With Small Cell Lung Cancer That Has Responded to Initial Therapy | NCT00004249 | Lung Cancer | QS21 keyhole limpet ... polysialic acid | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia | NCT00004052 | Leukemia | QS21 bcr-abl peptide... | 16 Years - | Memorial Sloan Kettering Cancer Center | |
| Vaccine Therapy Plus QS21 in Treating Patients With Prostate Cancer | NCT00036933 | Prostate Cancer | MUC-2-Globo H-K... QS21 | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Vaccine Therapy in Treating Patients With Primary Stage II Melanoma | NCT00005052 | Melanoma (Skin) | GM2-KLH vaccine QS21 adjuvant therap... | 18 Years - 80 Years | National Cancer Institute (NCI) | |
| Vaccine Therapy Plus QS21 in Treating Patients With Prostate Cancer | NCT00036933 | Prostate Cancer | MUC-2-Globo H-K... QS21 | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Vaccine Therapy Plus Immune Adjuvants in Treating Patients With Advanced Melanoma | NCT00003362 | Melanoma (Skin) | QS21 gp100 antigen incomplete Freu... sargramostim tyrosinase pept... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Vaccine Therapy Plus QS21 in Treating Patients With Small Cell Lung Cancer That Has Responded to Initial Therapy | NCT00004249 | Lung Cancer | QS21 keyhole limpet ... polysialic acid | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer | NCT00004929 | Prostate Cancer | MUC-2-KLH vacci... QS21 | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Vaccine Therapy and QS21 in Treating Patients With Metastatic Breast Cancer | NCT00470574 | Breast Cancer | QS21 sialyl LewisÂȘ-k... immunoenzyme te... immunologic tec... laboratory biom... | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Multivalent Conjugate Vaccine Trial for Patients With Biochem. Relapsed Prostate Cancer | NCT00579423 | Prostate Cancer | QS21 | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer | NCT00004929 | Prostate Cancer | MUC-2-KLH vacci... QS21 | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Multivalent Conjugate Vaccine Trial for Patients With Biochem. Relapsed Prostate Cancer | NCT00579423 | Prostate Cancer | QS21 | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Vaccine Therapy Plus QS21 in Treating Women With Breast Cancer Who Have No Evidence of Disease | NCT00003357 | Breast Cancer | GM2-KLH vaccine QS21 | 18 Years - | Memorial Sloan Kettering Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
